Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
出版年份 2021 全文链接
标题
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
作者
关键词
-
出版物
LANCET ONCOLOGY
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-04-28
DOI
10.1016/s1470-2045(21)00213-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
- (2021) Sultan Abdul-Jawad et al. CANCER CELL
- SARS-CoV-2 evolution during treatment of chronic infection
- (2021) Steven A. Kemp et al. NATURE
- Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
- (2021) Florian Krammer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
- (2021) Nicholas G. Davies et al. SCIENCE
- Approaches and Challenges in SARS-CoV-2 Vaccine Development
- (2020) Gabriel Dagotto et al. Cell Host & Microbe
- Italian survey on managing immune checkpoint inhibitors in oncology during COVID‐19 outbreak
- (2020) Marco Tagliamento et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
- (2020) Julian Braun et al. NATURE
- Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
- (2020) Francesco Passamonti et al. Lancet Haematology
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
- (2020) Suzanne Pickering et al. PLoS Pathogens
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
- (2020) Abi Vijenthira et al. BLOOD
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
- (2020) Victoria A. Avanzato et al. CELL
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
- (2020) Teresa Aydillo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)
- (2020) David S. Kim et al. Frontiers in Immunology
- Immune regulation by glucocorticoids can be linked to cell type–dependent transcriptional responses
- (2019) Luis M. Franco et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started